SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 84 filers reported holding SCPHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $234,960 | -30.1% | 33,000 | 0.0% | 0.02% | -28.1% |
| Q2 2023 | $336,270 | +12.3% | 33,000 | 0.0% | 0.03% | +3.2% |
| Q1 2023 | $299,310 | +126191.1% | 33,000 | 0.0% | 0.03% | +14.8% |
| Q4 2022 | $237 | -99.9% | 33,000 | +20.0% | 0.03% | +28.6% |
| Q3 2022 | $179,000 | +148.6% | 27,500 | +83.3% | 0.02% | +162.5% |
| Q2 2022 | $72,000 | -15.3% | 15,000 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $85,000 | +13.3% | 15,000 | 0.0% | 0.01% | +14.3% |
| Q4 2021 | $75,000 | – | 15,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 3,831,474 | $23,410,000 | 5.89% |
| AIGH Capital Management LLC | 642,154 | $3,924,000 | 0.71% |
| Ikarian Capital, LLC | 1,095,024 | $6,690,000 | 0.54% |
| Worth Venture Partners, LLC | 163,994 | $1,002,000 | 0.37% |
| Orbimed Advisors | 4,797,148 | $29,311,000 | 0.30% |
| RA Capital Management | 2,731,170 | $16,687,000 | 0.27% |
| J. Goldman & Co LP | 720,877 | $4,405,000 | 0.17% |
| DAFNA Capital Management LLC | 38,891 | $238,000 | 0.05% |
| BOOTHBAY FUND MANAGEMENT, LLC | 124,827 | $763,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 102,200 | $624,000 | 0.01% |